{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:51:09Z","timestamp":1784332269389,"version":"3.55.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/ede.0b013e3181a71279","type":"journal-article","created":{"date-parts":[[2009,8,13]],"date-time":"2009-08-13T18:55:58Z","timestamp":1250189758000},"page":"752-756","source":"Crossref","is-referenced-by-count":20,"title":["Hormone Replacement Therapy, Family History, and Breast Cancer Risk Among Postmenopausal Women"],"prefix":"10.1097","volume":"20","author":[{"given":"Robert","family":"Gramling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J.","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Silliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy L.","family":"Lash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20210207","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5","article-title":"Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction.","volume":"73","author":"Claus","year":"1994","journal-title":"Cancer"},{"key":"R2-23-20210207","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.","volume":"81","author":"Gail","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"R3-23-20210207","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.0.CO;2-B","article-title":"Family history and the risk of breast cancer: a systematic review and meta-analysis.","volume":"71","author":"Pharoah","year":"1997","journal-title":"Int J Cancer"},{"key":"R4-23-20210207","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.","volume":"289","author":"Chlebowski","year":"2003","journal-title":"JAMA"},{"key":"R5-23-20210207","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/jnci\/90.11.814","article-title":"Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer.","volume":"90","author":"Colditz","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R6-23-20210207","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0002-9378(11)90784-4","article-title":"Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies.","volume":"168","author":"Colditz","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"R7-23-20210207","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1472-6874-6-13","article-title":"Breast cancer risk associated with different HRT formulations: a register-based case-control study.","volume":"6","author":"Dinger","year":"2006","journal-title":"BMC Womens Health"},{"key":"R8-23-20210207","first-page":"815","article-title":"Conjugated estrogens and breast cancer risk in women.","volume":"67","author":"Hoover","year":"1981","journal-title":"J Natl Cancer Inst"},{"key":"R9-23-20210207","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/oxfordjournals.aje.a116041","article-title":"Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study.","volume":"134","author":"Kaufman","year":"1991","journal-title":"Am J Epidemiol"},{"key":"R10-23-20210207","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/oxfordjournals.aje.a117717","article-title":"Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women.","volume":"142","author":"Newcomb","year":"1995","journal-title":"Am J Epidemiol"},{"key":"R11-23-20210207","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ijc.2910370109","article-title":"The association of replacement estrogens with breast cancer.","volume":"37","author":"Nomura","year":"1986","journal-title":"Int J Cancer"},{"key":"R12-23-20210207","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1054\/bjoc.2001.1899","article-title":"A population-based cohort study of HRT use and breast cancer in southern Sweden.","volume":"85","author":"Olsson","year":"2001","journal-title":"Br J Cancer"},{"key":"R13-23-20210207","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/oxfordjournals.aje.a112901","article-title":"Family history of breast cancer as a risk indicator for the disease.","volume":"111","author":"Bain","year":"1980","journal-title":"Am J Epidemiol"},{"key":"R14-23-20210207","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00001648-199107000-00007","article-title":"Heterogeneity of the effect of family history on breast cancer risk.","volume":"2","author":"Byrne","year":"1991","journal-title":"Epidemiology"},{"key":"R15-23-20210207","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10654-005-0032-0","article-title":"Factors modifying the association between hormone-replacement therapy and breast cancer risk.","volume":"20","author":"Pesch","year":"2005","journal-title":"Eur J Epidemiol"},{"key":"R16-23-20210207","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1008817018942","article-title":"Association of family history and other risk factors with breast cancer risk (Sweden).","volume":"9","author":"Magnusson","year":"1998","journal-title":"Cancer Causes Control"},{"key":"R17-23-20210207","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1200\/JCO.2002.20.3.699","article-title":"Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer?","volume":"20","author":"Ursin","year":"2002","journal-title":"J Clin Oncol"},{"key":"R18-23-20210207","doi-asserted-by":"crossref","first-page":"973","DOI":"10.7326\/0003-4819-127-11-199712010-00004","article-title":"The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer.","volume":"127","author":"Sellers","year":"1997","journal-title":"Ann Intern Med"},{"key":"R19-23-20210207","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.7326\/0003-4819-127-12-199712150-00007","article-title":"Personal use of postmenopausal hormone replacement therapy by women physicians in the United States.","volume":"127","author":"McNagny","year":"1997","journal-title":"Ann Intern Med"},{"key":"R20-23-20210207","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"R21-23-20210207","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0197-2456(97)00078-0","article-title":"Design of the Women's Health Initiative clinical trial and observational study.","volume":"19","year":"1998","journal-title":"Control Clin Trials"},{"key":"R22-23-20210207","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/jama.1993.03510030062035","article-title":"Family history, age, and risk of breast cancer. Prospective data from the Nurses\u2019 Health Study.","volume":"270","author":"Colditz","year":"1993","journal-title":"JAMA"},{"key":"R23-23-20210207","article-title":"Modern Epidemiology. 2nd ed.","author":"Rothman","year":"1998"},{"key":"R24-23-20210207","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.1991.03460150089030","article-title":"A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer.","volume":"265","author":"Steinberg","year":"1991","journal-title":"JAMA"},{"key":"R25-23-20210207","first-page":"286","article-title":"Menopausal hormone replacement therapy and breast cancer: a meta-analysis.","volume":"79","author":"Sillero-Arenas","year":"1992","journal-title":"Obstet Gynecol"},{"key":"R26-23-20210207","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/jama.1987.03390020075030","article-title":"The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy.","volume":"257","author":"Wingo","year":"1987","journal-title":"JAMA"}],"container-title":["Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00001648-200909000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:18:00Z","timestamp":1618035480000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001648-200909000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/ede.0b013e3181a71279","relation":{},"ISSN":["1044-3983"],"issn-type":[{"value":"1044-3983","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}